Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
FT538 in Subjects With Advanced Hematologic Malignancies - Drug Trials For Money - Paid Clinical Trials

FT538 in Subjects With Advanced Hematologic Malignancies

FT538 in Subjects With Advanced Hematologic Malignancies
Conditions:   Acute Myeloid Leukemia;   AML, Adult;   Multiple Myeloma;   Myeloma
Interventions:   Drug: FT538;   Drug: Cyclophosphamid;   Drug: Fludarabine;   Drug: Daratumumab;   Drug: Elotuzumab
Sponsor:   Fate Therapeutics
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 5, 2020 / by / in
Comments